R&D channel feed

Mer­ck­'s Eli­av Barr on sub­cu­ta­neous Keytru­da, Sum­mit and deal shop­ping

7 months ago
People

Ex­elix­is’ drug staves off neu­roen­docrine tu­mor pro­gres­sion in broad swath of pa­tients

7 months ago

In sur­prise, study sug­gests Covid mR­NA vac­cines may boost can­cer im­munother­a­py ef­fi­ca­cy

8 months ago
Pharma
Coronavirus

Keytru­da and Lenvi­ma still have an­oth­er hill to climb fol­low­ing lat­est da­ta drop

8 months ago
Pharma

As­traZeneca un­veils what it calls ‘prac­tice-chang­ing’ Imfinzi da­ta in blad­der can­cer

8 months ago
Pharma

Scor­pi­on de­tails ear­ly da­ta on tar­get­ed breast can­cer drug as it seeks to chal­lenge No­var­tis, Roche

8 months ago

In­cyte gears up to face FDA once again with more Zynyz da­ta in rare anal can­cer

8 months ago
Pharma

Pfiz­er tees up Phase 3 test in weight man­age­ment — but in an un­ex­pect­ed area

8 months ago

Up­dat­ed: Bris­tol My­ers touts LAG-3 strat­e­gy in lung can­cer, but da­ta caveats damp­en ex­cite­ment

8 months ago

Nu­va­tion Bio to head to FDA with pooled ROS1-pos­i­tive lung can­cer da­ta

8 months ago

Up­dat­ed: GSK, iTeos re­ju­ve­nate strug­gling TIG­IT space with pos­i­tive Phase 2 Jem­per­li com­bo da­ta in lung can­cer

8 months ago
Pharma

Ar­bor Biotech­nolo­gies cuts ear­ly-stage dis­cov­ery work, lays off staff

8 months ago
People

Atea's poly­merase in­hibitor fails in late-stage Covid-19 treat­ment tri­al

8 months ago
Coronavirus

Onc­ter­nal stops can­cer tri­als and be­gins search for fu­ture busi­ness op­tions

8 months ago

Neu­ro­crine culls Phase 2 neu­ropsych med af­ter fail­ing to val­i­date ear­li­er da­ta

8 months ago

Seres' mi­cro­bio­me ther­a­py re­duces in­fec­tions in stem cell trans­plant pa­tients, but next steps are un­clear

8 months ago

Ful­crum's Phase 3 for old GSK drug fails, stock sinks

8 months ago

Gilead says twice-year­ly HIV pre­ven­tion shot suc­ceeds in sec­ond piv­otal tri­al

8 months ago
Pharma

Au­ra's in­frared light-ac­ti­vat­ed drug stops tu­mor growth and pre­serves vi­sion in eight eye can­cer pa­tients

8 months ago

Mod­er­na plans $1.1B in R&D and pro­gram cuts, de­lays break-even point to 2028

8 months ago

Sanofi buys in­to ra­dio­phar­ma­ceu­ti­cal field with $110M up­front, go­ing af­ter space held by No­var­tis

8 months ago
Deals
Pharma

No­vo Nordisk's long­stand­ing GLP-1 re­duced BMI by 7% in chil­dren in Phase 3 tri­al

8 months ago

Roche says its Car­mot-ac­quired obe­si­ty pill is ef­fec­tive in ear­ly study

8 months ago

In­novent Bi­o­log­ics high­lights sub­group of lung can­cer pa­tients in ear­ly-stage study of bis­pe­cif­ic

8 months ago
First page Previous page 25262728293031 Next page Last page
A service from the Financial Times